EverSource Wealth Advisors’s Ascendis Pharma A/S ASND Stock Holding History

EverSource Wealth Advisors’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$65.9K	Sell	247 -25	-9%	-$5.84K	﹤0.01%	1606
2026 Q1	$62.2K	Buy	272 +69	+34%	+$15.5K	﹤0.01%	1739
2025 Q4	$43.3K	Sell	203 -16	-7%	-$3.3K	﹤0.01%	1841
2025 Q3	$43.5K	Buy	219 +8	+4%	+$1.49K	﹤0.01%	1795
2025 Q2	$36.4K	Sell	211 -50	-19%	-$8.14K	﹤0.01%	1836
2025 Q1	$40.7K	Buy	261 +49	+23%	+$7K	﹤0.01%	1333
2024 Q4	$29.2K	Sell	212 -3	-1%	-$394	﹤0.01%	1438
2024 Q3	$32.1K	Buy	215 +1	+0.5%	+$135	﹤0.01%	1259
2024 Q2	$28.6K	Buy	214 +39	+22%	+$5.31K	﹤0.01%	1343
2024 Q1	$24.2K	Sell	175 -158	-47%	-$22.6K	﹤0.01%	1272
2023 Q4	$41.9K	Buy	333 +91	+38%	+$9.07K	﹤0.01%	966
2023 Q3	$22.7K	Buy	242 +152	+169%	+$14.2K	﹤0.01%	1081
2023 Q2	$8.03K	Buy	90 +30	+50%	+$2.61K	﹤0.01%	1545
2023 Q1	$6.43K	Buy	60 +25	+71%	+$2.86K	﹤0.01%	1553
2022 Q4	$4.28K	Hold	35	–	–	﹤0.01%	1667
2022 Q3	$4K	Buy	+35	New	+$3.32K	﹤0.01%	1412
2022 Q1	–	Sell	-10	Closed	-$1K	–	1702
2021 Q4	$1K	Buy	+10	New	+$1.49K	﹤0.01%	1677

Other funds holding ASND

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

EverSource Wealth Advisors's ASND Position: Q2 2026 in Review

EverSource Wealth Advisors reduced its Ascendis Pharma A/S (ASND) stake by 9.2% in Q2 2026, selling an estimated $5.84K and leaving 247 shares worth $65.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1606.

EverSource Wealth Advisors first reported a position in ASND in Q4 2021 and has held it in 17 quarters since. 313 funds tracked by Wall St. Rank hold ASND as of Q2 2026.

EverSource Wealth Advisors held 247 shares of Ascendis Pharma A/S worth $65.9K as of Q2 2026.
EverSource Wealth Advisors sold 25 Ascendis Pharma A/S shares in Q2 2026, an estimated $5.84K.
Ascendis Pharma A/S made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q2 2026, its #1606 holding.
EverSource Wealth Advisors first reported a position in Ascendis Pharma A/S in Q4 2021 and has held it in 17 quarters since.
313 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2026.

Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.